chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient.  A 42-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 17Mar2021 at 13:15 (at an age of 42-years-old) as second single dose for COVID-19 immunisation.   The patient had no medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks of vaccination.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as single dose for COVID-19 immunisation.   Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19.   On 18Mar2021, the patient experienced headache, fatigue and fever.  The patient did not receive any treatment for the events.  The clinical outcome of headache, fatigue and fever were resolved on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Weak; Achy; Mild congestion; Mild flu-like symptoms; Took temperature and it was slightly elevated; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in May2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included lisinopril dihydrate (LIZINOPRIL) and gliclazide (CLARITIN), both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 at 04:30, 2 weeks after the second vaccine, the patient experienced that he was weak, achy and had mild congestion. The patient took aspirin and it helped. On18May2021, the next day it was diminished and on 19May2021, the second next day it was gone. On an unknown date in 2021, 2 weeks later at the time of this report, the patient had the same albeit milder symptoms. This time the patient took temperature and it was slightly elevated. The patient took aspirin which again helped. The patient thought about it after and wished he had taken temperature during the first episode because he believed it to be mild flu-like symptoms. After the second time, the patient started to research and had not found anything like this, but at least wanted to let someone know about the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with aspirin. The clinical outcome of the events weak, achy, mild congestion and flu-like symptoms were resolved on 19May2021 and the same albeit milder symptoms along with temperature slightly elevated were resolved on an unspecified date in 2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Red Swollen Dot; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red Swollen Dot) and VACCINATION SITE PAIN (Sore Arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Swollen Dot) and VACCINATION SITE PAIN (Sore Arm). At the time of the report, VACCINATION SITE ERYTHEMA (Red Swollen Dot) and VACCINATION SITE PAIN (Sore Arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
This spontaneous report as received from an office manager refers to a female patient of unknown age, called to report a patient was given 0.65ml ZOSTAVAX (Lot number unspecified) intramuscularly instead of subcutaneously "about 2 weeks ago" in approximately 01-OCT-2012. The patient may have bled at the injection site on the same day of injection. The patient had no pertinent medical history or drug reactions/allergies. No lab diagnostics study was performed. No treatment was given. The outcome was unknown. The patient was in office when the adverse event happened and sought medical attention. Additional information is not expected.
Fever, fatigue, red swollen bulge at injection site 2 in diameter, pain. Gave ibuprofen.
Chest pain, muscle aches, fatigue, all exacerbated proportionally by degree of exertion
Shoulder pain, body rash heavier on neck region. Rash lead to scaling on neck. Clearing of throat consistently for several hours
Eyes got swollen and skin puffy and red, like a rash. Then it got to be like a sunburn and dry, inflamed, and peeled. Also, around the corners of my eyes was cracked and bleed. Ran for about 2weeks but had reoccurrences since. Ongoing issue. Hydrocortisone, Tacrolimus, and Loratadine, none had provided any relief.
Hospital course:  Patient is a 34 y.o. female with a PMH significant for TBI 2/2 MVC in 2018, spastic quadriparesis, and seizures who presented to the hospital on 8/23 due to worsening shortness of air. Per the patient's mother, the patient became febrile the morning of admission and upon checking her O2 sat, it was noted to be 85%. She was placed on 5L home O2 and brought to the hospital. The patient was found to have COVID. She was initially admitted to the hospital medicine service, however was noted to have decreased mentation requiring emergent intubation.  Post intubation the patient had a bronchoscopy with BAL performed. On the night of 8/24 into 8/25, the patient became hypotensive, was given 1L IVF, but remained hypotensive and was started on norepinephrine.  Shortly after initiation of norepinephrine, the patient became bradycardic therefore the patient was transitioned to epinephrine and BP and heart rate improved.  Per the patient's mother, the patient has had similar issues two time prior while on norepinephrine.  On the early morning of 8/25, the patient was weaned off of epinephrine and extubated to HFNC.  On 8/26, the patient was transitioned from HFNC to 5L NC and broad spectrum abx were stopped. On 8/29, the patient was upgraded to ICU status for closer monitoring. On 8/30, the patient was hypotensive wit SBP in the 70s, was given 1L IVF, transitioned back to HFNC,  and repeat infectious workup was obtained. On 8/31, the patient was transitioned back to regular NC and downgraded back to progressive care on 9/1.   On 9/4, the patient dropped her SpO2 to 75% on 4L NC. NT suction was performed, but catheter clogged due to secretions. The patient was placed on a NRB and SpO2 improved to 96%. The patient was then transitioned to 80% and 40L HFNC and initiated on mucomyst nebs. The patient stayed in the MICU and her oxygen was weaned down to 2L NC PRN over the past few days. She has continued getting mucomyst nebs, albuterol nebs, hypertonic saline nebs, chest PT, and cough assist. These interventions due help with her secretions. The patient's mother does have all these modalities for airway clearance at home and they are wanted to take the patient home. She has remained hemodynamically stable on midodrine and has tolerated RA mostly during the day with 2L PRN at night. The patient will be discharged home with current neb treatments as well as oxygen to use PRN. Home health services will resume and the team has reviewed the care plan/new medications with her mother. She states that she feels like the patient's care can be managed by them at home. She will follow up with her PCP in 1-2 weeks for further management.    Discharge Disposition/Condition Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)
patient had intractable pain from the right arm.  Nausea and vomiting and uncontrollable are movement.
A 15 years old, but was given Pfizer dose for 12 to 5 year old.  Return to clinic same day to receive 2nd dose of pediatric dose to provide adequate first dose amount.
rash began on 6OCT95 & mom described rash is bumpy, pink, raised approx 20 dots around diaper area, which last for about 2wks;No fever or itching;mom change diapers 6-7 times per day & applies desitin q diaper change;twin sister had rash
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 28-OCT-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L028666; expiry date 04-NOV-2016, (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
THE PATIENT GOT THE PFIZER PEDIATRIC DOSE (0.2 ML) BY MISTAKE INSTEAD OF GETTING HER MODERNA VACCINE BOOSTER
Four days after second dose of the Moderna vaccine, I am down with rashes around my neck area. The rash is not raised or have bumps.  The rash is red, flat, dry, itchy and very sensitive and spreads on neck.   I began taking Zyrtec and cortisone cream which has not helped.  I also tried diphenhydramine and that did not help.  This rash lasted for about 6 days and went away.  The same rash has now came back about 30  days after my  second vaccine.
Became pale c/o hearing and vision impairment, upset stomach. Blood pressure 80/66, ten minutes later Blood pressure 100/66, went to ER via parents. Patient  being checked by EMT's, called mother 2 pm daughter is fine no adverse results. No need for epi.
102.8 fever for 3 days, hives for 14 days, pain in abdomen for 5 days, as of 11/5 blurred vision and dizziness treatment included MEDROL DOSEPAK, followed by prednisone injection and oral prednisone.
Injection site became sore and swollen. On 10/15 measured 40x45 millimeters across the middle. Hot and red. 10/16/09 decresed to 35x45 millimeters across w/no redness.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 42 year-old male patient received bnt162b2 (BNT162B2), administration date 26Aug2021 16:00 (Batch/Lot number: unknown) at the age of 41 years as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Cipro, reaction(s): "known allergies: Cipro". The following information was reported: RASH (non-serious) with onset 27Aug2021, outcome "not recovered", described as "Generalize rash"; MYALGIA (non-serious) with onset 27Aug2021, outcome "not recovered", described as "muscle aches"; CHILLS (non-serious) with onset 27Aug2021, outcome "not recovered", described as "chills"; HEADACHE (non-serious) with onset 27Aug2021, outcome "not recovered", described as "headache". Therapeutic measures were taken as a result of rash, myalgia, chills, headache. Additional information: No, other vaccine in four weeks, No, other medications in two weeks. Ibuprofen and Benadryl were used for AE treatment. No, Covid prior vaccination. No, Covid tested post vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
PATIENT REQUESTED PFIZER COVID19 BIVALENT AND RECEIVED MODERNA COVID BIVALENT
Pfizer-BioNTech Covid-19 Vacine EUA Left side of my face feels tingly. It?s not swollen and still functional. Just tingly. Same feeling as if your foot falls asleep. No treatment yet. Waiting to see if it goes away in a few days.
18 pounds weight lost; Complete loss of taste and smell and then only partial of taste and smell; Complete loss of taste and smell and then only partial of taste and smell; Taste buds have changed drastically as everything tastes bad; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 17-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 13May2021 at 12:00 PM (at the age of 17 years), as dose 1, single, for COVID-19 immunization. The patient's medical history included COVID-19 (prior vaccination). There were no concomitant medications. The patient had no known allergies. No other vaccine was administered in four weeks. The vaccine was administered in a public health clinic or administration facility. In 2021 (reported as 13Apr2021 at 04:00 PM; pending clarification), the patient experienced complete loss of taste and smell for 3 weeks and then only partial of taste and smell. Taste buds have changed drastically as everything tastes bad (2021). In 2021, the patient also experienced 18 pounds weight lost (lost 18 lbs). The events resulted in doctor or other healthcare professional office or clinic visit. No treatment was administered for the events. The patient underwent COVID-19 nasal swab test that was negative on 01Jun2021. The patient had not recovered from the events.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sore throat, swollen glands, body aches, extreme fatigue, temp 100.9.
Bad back aches; Muscle sore; Throwing up; This is a spontaneous report from a contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8730) via an unspecified route of administration in the right arm on 28Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, on an unspecified date. The patient did not receive any concomitant medications within 2 weeks of the vaccine. Prior to the COVID-19 vaccination, the patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was had not been tested for COVID-19. On 29Mar2021 at 02:00, the patient experienced bad back aches, muscles sore and throwing up. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the reported events. The clinical outcome of the events bad back aches, muscles sore, throwing up was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 07-JUN-2013, the patient was vaccinated with a dose of GARDASIL, (lot # H021608, expiry date 13-AUG-2015), which was exposed to 31 Fahrenheit for 1 hour. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Information has been received from a Doctor of Pharmacy concerning a 38 year old female diabetic who on 30-NOV-2006 was vaccinated in the arm with her first dose of Pneumovax 23, lot #655055/0749F.  The patient also received an unspecified influenza virus vaccine in the other arm.  On the same day the patient developed a red area around the injection site approximately 5 inches in diameter.  The pharmacist indicated proper aseptic vaccination technique was employed and would like a lot check performed.  The patient's outcome was unknown.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Follow up information has been received from  Registered Pharmacist concerning the 36 year old patient (originally reported as 38), who on 30-NOV-2006 was vaccinated "SQ" in the left deltoid with her first dose of Pneumovax 23, lot #655054/0749F.  It was reported that: "Aseptic technique was used; IM injection in left deltoid after prepping vial and arm with separate alcohol swabs.  No blood was noted upon needle withdrawal.  Patient noted no initial complaint.  Patient called the following day at approximately 10:00 a.m. noting inflamed left deltoid and a swollen area of approximately 5 inches by 6 inches.  She had called a physician; recommendations of ice/BENADRYL.  I reinforced those recommendations and strongly urged patient to follow up with physician and...pharmacy."  On 02-DEC-2006 the reporter called the patient, she was "fine" and the redness was resolving.  She was reported as recovered from inflamed left deltoid and swollen area.  Additional information is not expected.
2" by 4" red, swollen, tender area of skin at sit eof mumps vaccination given on 9-13-06.  Upper left arm.  Some aching.
This spontaneous report was received from a medical assistance referring to a 9 year old male patient. Concurrent condition was reported as Attention Deficit Hyperactivity disorder (ADHD). Drug reactions and allergies were reported as none. On 09-APR-2015, the patient received the first dose of GARDASIL (dosage unknown; intramuscular, lot no. K007828, Exp 02-MAR-2017). On 09-JUN-2015, the patient was vaccinated with the second dose of GARDASIL (lot # K007828:exp date 02-MAR-2017), intramuscularly (dosage, anatomical location and concentration were not reported). Concomitant medication reported as METADATE. On 09-JUN-2015, the patient experienced unspecified facial swelling and unspecified facial rash. The mother of the patient then gave her son BENADRYL on the same date. On 11-JUN-2015, the patient was seen in the physicians office and prescribed Hydrocortisone (formulation and manufacturer unknown). On 16-JUN-2015, the patient was prescribed an epinephrine pen and ordered to receive unspecified allergy test and a complete blood count. Results were not available yet. At the time of the report the outcome of facial swelling and unspecified facial rash was unknown. Upon internal review the events were considered to be medically significant. Additional information has been requested.
CHILD C/O PAIN WHEN TRIED TO DO A CARTWHEEL IN GYMNASTICS, MOC LOOKED AT ARM SAW DISCOLORED (BLACKISH) MARK ABOUT 3" IN DIAMETER, COMING UNDER BANDAID ON RT. DELTOID, AREA IS TAUT AND SMOOTH.  NO OTHER COMPLAINT, NO FEVER.  MOC JUST WANTED EXPLANATION AS FAMILY IS LEAVING FOR VACATION AND SO CONCERNED.  EXPLANATION OF 4TH OR 5TH REACTION TO DTaP POSSIBLE AND ALSO HOW A BRUISE CAN HAPPEN WITH WITH A SHOT, OTHER SYMPTOMS TO WATCH FOR AND IF REALLY CONCERNED SEE PEDIATRICIAN.  MOC DECIDED SHE WILL TAKE IZ. RECORDS WITH THEM, JUST IN CASE. MOC RELIEVED.
fever 31MAR;blisters vesicles started 2APR98;more noted 3APR98 confirmed by visit to office;
Patient stated on the 3rd day after receiving the vaccines she was not feeling well. She was very sick to the stomach. She has extreme fatigue. She experienced brain fog. She can not remember things. She is experiencing server headaches. Patient stated that she walks with a limb but since receiving the vaccination the limb has gotten worst.
On 12/04/2022, I flew back from traveling out of town and I was unable to equalize pressure in my right ear. When I woke up on 12/05/2022, I had nasal congestion, sore throat, coughing, sneezing, and I still couldn't clear my right ear. I took an at home COVID-19 test and the results were positive. I slept most of that day. Tuesday, I was still under the weather. I felt a little bit better but was still having symptoms. I went to a local walk-in clinic, and they diagnosed an ear infection. I let them know at the clinic, that I had tested positive for COVID-19 with an at home test. They prescribed antibiotics for the ear infection and advised that I call them back if things get worse. Things seem to be getting slowly but steadily better.
Rapid heart rate - 136. Lasted 5 hours. Normal around 10 PM.
Atrial fibrillation for 12 hours and then it disappeared.  I have never before experienced AFIB.  It was all recorded on my Apple Watch. My resting heart rate normally around 60 bpm was elevated to around 75. Around 10 am everything was back to normal.
Pt. experienced chest pain for 20 minutes after 1st Anthrax, frequent PACs after 3rd shot.Fatigue started after 2nd shot and persisted through 3rd shot.Pt. also experienced decreased ability to exercise.
Pharmacist went to inject vaccine, when he did the vaccine leaked out of the syringe and little to no vaccine went into the patient's arm.  Called gsk and they said to revaccinate the patient but to call cdc to see when the patient could be revaccinated.  Called cdc and they said to vaccinate the patient anytime, could be the same day.  So patient was revaccinated that day.